<DOC>
	<DOC>NCT01480258</DOC>
	<brief_summary>This study will determine whether subjects who receive V419 at 2, 4, and 11 to 12 months of age have an acceptable response to the vaccine. this study will also determine whether the immune response to V419 is similar to that of subjects who received a licensed vaccine control.</brief_summary>
	<brief_title>Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy infant able to attend all study visits Parent(s)/legal representative are able to read, understand, and complete study questionnaires History of congenital or acquired immunodeficiency Received or is expected to receive immunosuppressive agents or systemic immunomodulatory steroids History of leukemia, lymphoma, malignant melanoma, or myeloproliferative disorder Hypersensitivity to any of the vaccine components or history of a lifethreatening reaction to a vaccine containing the same substances as the study vaccines or concomitant study vaccines Has any chronic illness that could interfere with study conduct or completion Received any immune globulin, blood, or bloodderived products since birth Received a dose of hepatitis B vaccine prior to study entry Vaccinated with any acellular pertussis or whole cell pertussis based combination vaccines, Haemophilus influenzae type b conjugate, poliovirus, pneumococcal conjugate or pneumococcal polysaccharide, rotavirus vaccine, or combination thereof Fever within 24 hours prior to enrollment Received any nonstudy vaccine within 30 days prior to enrollment, except for inactivated influenza vaccine, which is permitted 14 days or more prior to enrolment Has a coagulation disorder Has developmental delay or neurological disorder Participant or his/her mother has a medical history of hepatitis B surface antigens (HBsAg) seropositivity History of Haemophilus influenzae type b, hepatitis B, diphtheria, tetanus, pertussis, poliomyelitis, rotavirus gastroenteritis, or invasive pneumococcal infection</criteria>
	<gender>All</gender>
	<minimum_age>46 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>combination vaccine</keyword>
	<keyword>diphtheria</keyword>
	<keyword>pertussis</keyword>
	<keyword>tetanus</keyword>
	<keyword>hepatitis B</keyword>
	<keyword>Hep B</keyword>
	<keyword>Haemophilus influenzae b</keyword>
	<keyword>Hib</keyword>
	<keyword>polio</keyword>
	<keyword>poliovirus</keyword>
</DOC>